Cargando…

COVID-19 and cardiovascular diseases

The coronavirus disease 2019 (COVID-19) remains a global public health emergency. Despite being caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), besides the lung, this infectious disease also has severe implications in the cardiovascular system. In this review, we summarize di...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Fan, Liu, Feng, Wang, Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717280/
https://www.ncbi.nlm.nih.gov/pubmed/33226078
http://dx.doi.org/10.1093/jmcb/mjaa064
_version_ 1783619301558714368
author Liu, Fan
Liu, Feng
Wang, Lu
author_facet Liu, Fan
Liu, Feng
Wang, Lu
author_sort Liu, Fan
collection PubMed
description The coronavirus disease 2019 (COVID-19) remains a global public health emergency. Despite being caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), besides the lung, this infectious disease also has severe implications in the cardiovascular system. In this review, we summarize diverse clinical complications of the heart and vascular system, as well as the relevant high mortality, in COVID-19 patients. Systemic inflammation and angiotensin-converting enzyme 2-involved signaling networking in SARS-CoV-2 infection and the cardiovascular system may contribute to the manifestations of cardiovascular diseases. Therefore, integration of clinical observations and experimental findings can promote our understanding of the underlying mechanisms, which would aid in identifying and treating cardiovascular injury in patients with COVID-19 appropriately.
format Online
Article
Text
id pubmed-7717280
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77172802020-12-09 COVID-19 and cardiovascular diseases Liu, Fan Liu, Feng Wang, Lu J Mol Cell Biol Reviews The coronavirus disease 2019 (COVID-19) remains a global public health emergency. Despite being caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), besides the lung, this infectious disease also has severe implications in the cardiovascular system. In this review, we summarize diverse clinical complications of the heart and vascular system, as well as the relevant high mortality, in COVID-19 patients. Systemic inflammation and angiotensin-converting enzyme 2-involved signaling networking in SARS-CoV-2 infection and the cardiovascular system may contribute to the manifestations of cardiovascular diseases. Therefore, integration of clinical observations and experimental findings can promote our understanding of the underlying mechanisms, which would aid in identifying and treating cardiovascular injury in patients with COVID-19 appropriately. Oxford University Press 2020-11-23 /pmc/articles/PMC7717280/ /pubmed/33226078 http://dx.doi.org/10.1093/jmcb/mjaa064 Text en © The Author(s) (2020). Published by Oxford University Press on behalf of Journal of Molecular Cell Biology, IBCB, SIBS, CAS. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Reviews
Liu, Fan
Liu, Feng
Wang, Lu
COVID-19 and cardiovascular diseases
title COVID-19 and cardiovascular diseases
title_full COVID-19 and cardiovascular diseases
title_fullStr COVID-19 and cardiovascular diseases
title_full_unstemmed COVID-19 and cardiovascular diseases
title_short COVID-19 and cardiovascular diseases
title_sort covid-19 and cardiovascular diseases
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717280/
https://www.ncbi.nlm.nih.gov/pubmed/33226078
http://dx.doi.org/10.1093/jmcb/mjaa064
work_keys_str_mv AT liufan covid19andcardiovasculardiseases
AT liufeng covid19andcardiovasculardiseases
AT wanglu covid19andcardiovasculardiseases